Oncology Corporate Profile
Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of smallmolecule drugs as innovative treatments to serve high unmet medical needs. The company has its corporate headquarters in Allschwil/Basel, Switzerland where it was founded in 1997.
|Valchlor®||mechlorethamine||Valchlor® is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides'type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.|
|Brand / Product||Class||Area of Study||Phase||Partnership|
|macitentan||endothelin receptor antagonist (ERA)||Glioblastoma Multiforme (GBM)||I|